Organon & Co
727 hedge funds and large institutions have $4.13B invested in Organon & Co in 2023 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 225 increasing their positions, 292 reducing their positions, and 97 closing their positions.
83% more call options, than puts
Call options by funds: $27.7M | Put options by funds: $15.1M
1% more capital inflows, than outflows
Capital inflows: $358M | Capital outflows: $355M
0.04% more ownership
Funds ownership: 77.96% → 78.01% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less funds holding
Funds holding: 768 → 727 (-41)
23% less repeat investments, than reductions
Existing positions increased: 225 | Existing positions reduced: 292
38% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 97
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$31.6M |
| 2 |
Magnetar Financial
Evanston,
Illinois
|
+$31.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$27.4M |
| 4 |
Millennium Management
New York
|
+$16M |
| 5 |
JP Morgan Chase
New York
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$75.3M |
| 2 |
Bank of New York Mellon
New York
|
-$53.3M |
| 3 |
Impax Asset Management Group
London,
United Kingdom
|
-$32.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$30.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.9M |
OGN Hedge Fund Activity: Q2 2023 in Review
727 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q2 2023, worth a combined $4.13B — down 12% from $4.67B a quarter earlier.
Sellers outnumbered buyers: 97 funds closed out of OGN and 60 opened new positions — a net loss of 37 holders — while 292 trimmed existing stakes and 225 added.
The largest buyer was Goldman Sachs, adding an estimated $31.6M. The largest seller was Armistice Capital, exiting entirely with an estimated $75.3M sold.
- 727 institutional investors held Organon & Co (OGN) as of Q2 2023, down from 768 in Q1 2023.
- Funds reported $4.13B of Organon & Co stock for Q2 2023, down 12% quarter-over-quarter.
- 60 funds opened new Organon & Co positions in Q2 2023 and 97 closed out, a net change of -37 holders.
- The largest Organon & Co buyer in Q2 2023 was Goldman Sachs, an estimated $31.6M added.
- The largest Organon & Co seller in Q2 2023 was Armistice Capital, an estimated $75.3M sold.
Based on aggregated 13F filings for Q2 2023.